Literature DB >> 30471365

Effects of three common lumbar interbody fusion procedures for degenerative disc disease: A network meta-analysis of prospective studies.

En-Yuan Lin1, Yu-Kai Kuo2, Yi-No Kang3.   

Abstract

OBJECTIVES: Lumbar interbody fusion (LIF) is a treatment option for patients with degenerative disc disease (DDD). However, the effects of the most common LIF procedures-posterior LIF, transforaminal LIF, and anterior LIF-for the treatment of patients with DDD remain controversial. This study evaluated the pain and function caused by the LIF procedures for the treatment of patients with DDD.
METHODS: Cochrane library, EMBASE, Ovid Medline, and PubMed were searched from inception to July 17, 2018. We only included prospective studies comparing the LIF procedures for treating patients with DDD. Pain score, Oswestry disability index (ODI) score, and operative time were analyzed in a contrast-based consistency model. Results are reported in weighted mean difference (WMD) and 95% confidence interval (CI).
RESULTS: This study included eight prospective studies that recruited 503 patients for the LIF procedures. Minimally invasive posterior LIF resulted in lower pain scores than open transforaminal LIF (WMD: -1.45, 95% CI: -2.27 to -0.63) and open posterior LIF (WMD: -0.61, 95% CI: -1.10 to -0.12). It also resulted in a lower ODI score than open transforaminal LIF (WMD: -15.34, 95% CI: -21.76 to -8.91), anterior LIF (WMD: -15.64, 95% CI: -26.37 to -4.91), minimally invasive transforaminal LIF (WMD: -11.63, 95% CI: -16.86 to -6.40), and open posterior LIF (WMD: -10.93, 95% CI: -16.07 to -5.79). Small study effects were not detected in any consistency models.
CONCLUSIONS: Although minimally invasive posterior LIF has longer operative time than anterior LIF, it is associated with lower pain and ODI scores. Therefore, minimally invasive posterior LIF may be a superior LIF procedure for patients with DDD.
Copyright © 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anterior lumbar interbody fusion; Degenerative disk disease; Posterior lumbar interbody fusion; Transforaminal lumbar interbody fusion

Mesh:

Year:  2018        PMID: 30471365     DOI: 10.1016/j.ijsu.2018.11.009

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Application of electromagnetic navigation in endoscopic transforaminal lumbar interbody fusion: a cohort study.

Authors:  Hao Zhang; Derong Xu; Chao Wang; Kai Zhu; Jianwei Guo; Chong Zhao; Jialuo Han; Houchen Liu; Xuexiao Ma; Chuanli Zhou
Journal:  Eur Spine J       Date:  2022-06-24       Impact factor: 2.721

2.  Testicular versus percutaneous epididymal sperm aspiration for patients with obstructive azoospermia: a systematic review and meta-analysis.

Authors:  Kuan-Wei Shih; Ping-You Shen; Chien-Chih Wu; Yi-No Kang
Journal:  Transl Androl Urol       Date:  2019-12

3.  Safety of Lumbar Interbody Fusion Procedures for Degenerative Disc Disease: A Systematic Review With Network Meta-Analysis of Prospective Studies.

Authors:  Kuan-Yu Chi; Shih-Hao Cheng; Yu-Kai Kuo; En-Yuan Lin; Yi-No Kang
Journal:  Global Spine J       Date:  2020-07-28

Review 4.  Treatment of Intervertebral Disc Degeneration.

Authors:  Jingguo Xin; Yongjie Wang; Zhi Zheng; Shuo Wang; Shibo Na; Shaokun Zhang
Journal:  Orthop Surg       Date:  2022-04-29       Impact factor: 2.279

5.  Infection rate among nutritional therapies for acute pancreatitis: A systematic review with network meta-analysis of randomized controlled trials.

Authors:  Ping-Han Hsieh; Hsiu-Yueh Su; Chung-Yuan Lin; Yi-No Kang; Chun-Chao Chang
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

6.  An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease.

Authors:  Hsin-I Tuan; Sheng-Chu Chi; Yi-No Kang
Journal:  Drug Des Devel Ther       Date:  2020-01-17       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.